PLK4: A Master Regulator of Centriole Duplication and Cancer Susceptibility

Comprehensive genomic and functional analysis of PLK4, a serine/threonine-protein kinase essential for centriole biogenesis and implicated in microcephaly and tumorigenesis.

Gene Information Card

Symbol PLK4
Full Name polo like kinase 4
Gene Type protein-coding
Chromosomal Location 4q28.1
NCBI Gene ID 10733 ncbi.nlm.nih.gov/gene/10733
Ensembl ID ENSG00000142731
UniProt ID O00444
OMIM ID 605031
HGNC ID 9077
Aliases SAK, STK18, MCPH7

Description

PLK4 encodes a serine/threonine-protein kinase that is a key regulator of centriole duplication. It is required for the formation of a single procentriole per mother centriole during the cell cycle. PLK4 activity is tightly controlled; overexpression leads to centriole amplification and genomic instability, while loss-of-function mutations cause centriole depletion and are associated with primary microcephaly. The gene is also implicated in various cancers, including breast, colorectal, and hepatocellular carcinoma.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Primary microcephaly 7 (MCPH7) Loss-of-function mutations in PLK4 impair centriole duplication, leading to reduced neural progenitor cell proliferation and small brain size. OMIM #605031; PMID: 24607474
Breast cancer PLK4 overexpression drives centrosome amplification, aneuploidy, and tumor progression. COSMIC; PMID: 25605248
Colorectal cancer PLK4 upregulation correlates with poor prognosis and promotes chromosomal instability. COSMIC; PMID: 29127259
Hepatocellular carcinoma PLK4 amplification and overexpression contribute to centrosome clustering and tumor growth. COSMIC; PMID: 30093503

Expression Profile

Tissue Expression
Tissue nTPM level
Testis 15.2 Medium
Bone marrow 10.5 Medium
Lymph node 8.3 Low
Brain 4.1 Low
Liver 3.8 Low
Cell Line Expression
Cell Line nTPM Notes
HeLa 12.1 Cervical cancer cell line
MCF7 9.8 Breast cancer cell line
HCT116 11.4 Colorectal cancer cell line
HEK293 7.2 Embryonic kidney cell line
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.277C>T (p.Arg93*) Nonsense Rare Loss of function; associated with microcephaly
c.1465G>A (p.Glu489Lys) Missense Rare Impaired kinase activity; microcephaly
c.1912C>T (p.Arg638Trp) Missense Rare Reduced centriole duplication; microcephaly
Amplification Copy number gain Frequent in cancer Overexpression; centrosome amplification
Mutation functional classification

Loss of Function (LOF)

Nonsense and missense mutations (e.g., p.Arg93*, p.Glu489Lys) that reduce or abolish kinase activity, leading to centriole duplication defects and microcephaly.

Gain of Function (GOF)

Gene amplification and overexpression in cancers, resulting in centrosome amplification and genomic instability.

Dominant Negative (DN)

Not well documented; some missense variants may exert dominant-negative effects by interfering with wild-type PLK4 function, but evidence is limited.

Pathways

• Centrosome duplication (Reactome: R-HSA-380270)
• Cell cycle (KEGG: hsa04110)
• PLK4 signaling events (PID: plk4_pathway)

Protein Summary

PLK4 is a 970-amino acid serine/threonine-protein kinase with an N-terminal kinase domain, a polo-box domain, and a C-terminal cryptic polo-box. It localizes to centrioles and is essential for procentriole formation. Autophosphorylation and degradation by the proteasome regulate its activity. In cancer, PLK4 overexpression promotes centrosome amplification, while in microcephaly, loss-of-function mutations impair neurogenesis.

Related Products

Product name Cat.No. Species Gene ID
No Data
Contact Us
*
*
*
How did you hear about us: